Ward J, Berrien-Elliott MM, Gomez F, Luo J, et al. Phase I/Dose Expansion Trial of Brentuximab vedotin/Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma. Blood 2021 Nov 15. pii: 477971. doi: 10.1182/blood.2021011894.
PMID: 34780623